Cargando…

Role of Organic Cation Transporter 1, OCT1 in the Pharmacokinetics and Toxicity of cis-Diammine(pyridine)chloroplatinum(II) and Oxaliplatin in Mice

PURPOSE: The goal of this study was to test the hypothesis that by controlling intracellular uptake, organic cation transporter 1, Oct1 is a key determinant of the disposition and toxicity of cis-diammine(pyridine)chloroplatinum(II)(CDPCP) and oxaliplatin. METHODS: Pharmacokinetics, tissue accumulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shuanglian, Chen, Ying, Zhang, Shuzhong, More, Swati S., Huang, Xiaozhu, Giacomini, Kathleen M.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer US 2010
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040319/ https://www.ncbi.nlm.nih.gov/pubmed/21104302 http://dx.doi.org/10.1007/s11095-010-0312-6

Ejemplares similares

cis-Diammine(glycolato-κ(2) O (1),O (2))platinum(II)
por: Wang, Qing-Kun, et al.
Publicado: (2009)

Short term serum pharmacokinetics of diammine silver fluoride after oral application
por: Vasquez, Elsa, et al.
Publicado: (2012)

Extent of the Acidification by N7-Coordinated cis-Diammine-Platinum(II) on the Acidic Sites of Guanine Derivatives
por: Song, Bin, et al.
Publicado: (1996)

The Fruit Hull of Gleditsia sinensis Enhances the Anti-Tumor Effect of cis-Diammine Dichloridoplatinum II (Cisplatin)
por: Kim, Kyun Ha, et al.
Publicado: (2016)

Pharmacokinetic Evaluation of (Glycolato‐O, O′) diammine Platinum(II) in Lung Lymph in Sheep
por: Koizumi, Tomonobu, et al.
Publicado: (1993)

Alpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis-diammined dichloridoplatium
por: TANG, BO, et al.
Publicado: (2011)

Potentiation of cis‐Diammine(1, 1‐cyclobutanedicarboxylato)platinum(II) by Amphotericin B in BALB/c Nude Mice Bearing Human Ovarian Carcinoma Cells
por: Kojima, Masayoshi, et al.
Publicado: (1994)

Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-Fluorouracil for postoperative locoregional recurrent esophageal cancer
por: Jingu, Keiichi, et al.
Publicado: (2006)

Alpinetin inhibits lung cancer progression and elevates sensitization drug-resistant lung cancer cells to cis-diammined dichloridoplatium
por: Wu, Lin, et al.
Publicado: (2015)

Telomerase Activity Correlates with Growth of Transplantable Osteosarcomas in Rats Treated with cis‐Diammine Dichloroplatinum or the Angiogenesis Inhibitor AGM‐1470
por: Kido, Akira, et al.
Publicado: (1998)

[Retracted] Alpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis‑diammined dichloridoplatium
por: Tang, Bo, et al.
Publicado: (2023)

Organic cation transporter 1 (OCT1) modulates multiple cardiometabolic traits through effects on hepatic thiamine content
por: Liang, Xiaomin, et al.
Publicado: (2018)

The full spectrum of OCT1 (SLC22A1) mutations bridges transporter biophysics to drug pharmacogenomics
por: Yee, Sook Wah, et al.
Publicado: (2023)

EAT/mcl‐1, a Member of the bcl‐2 Related Genes, Confers Resistance to Apoptosis Induced by cis‐Diammine Dichloroplatinum (II) via a p53‐Independent Pathway
por: Ando, Takashi, et al.
Publicado: (1998)

On pyridine chloronium cations
por: Pröhm, Patrick, et al.
Publicado: (2023)

High Throughput Screening of a Prescription Drug Library for Inhibitors of Organic Cation Transporter 3, OCT3
por: Chen, Eugene C., et al.
Publicado: (2022)

Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cells
por: Olszewski, Ulrike, et al.
Publicado: (2011)

Effect of Glutathione Bio-Molecule on Tooth Discoloration Associated with Silver Diammine Fluoride
por: Sayed, Mahmoud, et al.
Publicado: (2018)

Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia
por: Nishizawa, Kei, et al.
Publicado: (2019)

Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-induced Peripheral Neurotoxicity
por: Nepal, Mahesh R., et al.
Publicado: (2022)

Cloning and Functional Characterization of Dog OCT1 and OCT2: Another Step in Exploring Species Differences in Organic Cation Transporters
por: Meyer, Marleen Julia, et al.
Publicado: (2022)

No significant influence of OCT1 genotypes on the pharmacokinetics of morphine in adult surgical patients
por: Kuhlmann, Ida, et al.
Publicado: (2021)

Transcription factor organic cation transporter 1 (OCT-1) affects the expression of porcine Klotho (KL) gene
por: Li, Yan, et al.
Publicado: (2016)

Impact of Promoter Polymorphisms on the Transcriptional Regulation of the Organic Cation Transporter OCT1 (SLC22A1)
por: Bokelmann, Kristin, et al.
Publicado: (2018)

Effect of silver diammine fluoride on micro-ecology of plaque from extensive caries of deciduous teeth - in vitro study
por: Liu, Bao ying, et al.
Publicado: (2020)

The Manufacture and Characterization of Silver Diammine Fluoride and Silver Salt Crosslinked Nanocrystalline Cellulose Films as Novel Antibacterial Materials
por: Jackson, John, et al.
Publicado: (2021)

Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance
por: Heise, Michael, et al.
Publicado: (2012)

Characterization and Pharmacokinetic Evaluation of Oxaliplatin Long-Circulating Liposomes
por: Cheraga, Nihad, et al.
Publicado: (2021)

Organic cation transporter 3 (Oct3) is a distinct catecholamines clearance route in adipocytes mediating the beiging of white adipose tissue
por: Song, Wenxin, et al.
Publicado: (2019)

cis-Dichloridobis(2-phenylpyridine-κN)platinum(II)
por: Yoshinari, Nobuto, et al.
Publicado: (2010)

cis-Dibromidobis(2-phenylpyridine-κN)platinum(II)
por: Ha, Kwang
Publicado: (2012)

The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicin
por: Andreev, Emil, et al.
Publicado: (2016)

Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment
por: Grimm, Daniel, et al.
Publicado: (2016)

Organic cation transporter 1 (OCT1) is involved in pentamidine transport at the human and mouse blood-brain barrier (BBB)
por: Sekhar, Gayathri N., et al.
Publicado: (2017)

Expansion of Knowledge on OCT1 Variant Activity In Vitro and In Vivo Using Oct1/2(−/−) Mice
por: Morse, Bridget L., et al.
Publicado: (2021)

Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients
por: Matthaei, Johannes, et al.
Publicado: (2021)

A Physiologically-Based Pharmacokinetic Model of Trimethoprim for MATE1, OCT1, OCT2, and CYP2C8 Drug–Drug–Gene Interaction Predictions
por: Türk, Denise, et al.
Publicado: (2020)

DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma
por: Schaeffeler, Elke, et al.
Publicado: (2011)

Role of the Plasma Membrane Transporter of Organic Cations OCT1 and Its Genetic Variants in Modern Liver Pharmacology
por: Lozano, Elisa, et al.
Publicado: (2013)

Translational Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Oxaliplatin and Irinotecan in Colorectal Cancer
por: Zhu, Jinwei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rbq2hnnb4hf0kl49soen8t3vqg